A quantitative assessment of sleep laboratory activity in the United States

Division of Sleep Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine (Impact Factor: 3.05). 02/2005; 1(1):23-6.
Source: PubMed


To determine the total number of active sleep laboratories in the United States and the number of polysomnograms conducted on a yearly basis in these laboratories.
All members of the AASM and all AASM accredited sleep laboratory directors received a questionnaire addressing their laboratory and its volume. In three states, multiple telephone calls to AASM members were used to correctly identify the absolute number of labs and their PSG volume in those states. Extrapolating from the number of labs studies identified per questionnaire relative to the correct number (per calls) in those states and, then applying this ratio to the entire US, the total number of labs and studies was determined.
Our data suggests that there are, in the year 2001, 1,292 sleep laboratories conducting 1,165,135 polysomnograms per year. This comes to 427 PSG's/year per 100,000 population in the United States.
These data suggest that there are a relatively large number of sleep laboratories in the US conducting a substantial number of PSG's. However, there was considerable variability in this volume between states that did not relate to known markers of healthcare utilization. These numbers have likely increased since 2001.

Download full-text


Available from: Naoko Tachibana, May 15, 2015
  • Source
    • "Nevertheless, the services are still underdeveloped compared with services in developed countries. Table 2 shows a comparison between sleep medicine activity in the KSA and other countries.[78910] Although the number of beds/100,000 people has doubled, this number is still far lower than in developed countries. "
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: We conducted this national survey to quantitatively assess sleep medicine services in the Kingdom of Saudi Arabia (KSA) and to identify obstacles that specialists and hospitals face, precluding the establishment of this service. MATERIALS AND METHODS: A self-administered questionnaire was designed to collect the following: General information regarding each hospital, information regarding sleep medicine facilities (SFs), the number of beds, the number of sleep studies performed and obstacles to the establishment of SFs. The questionnaire and a cover letter explaining the study objectives were mailed and distributed by respiratory care practitioners to 32 governmental hospitals and 18 private hospitals and medical centers in the KSA. RESULTS: The survey identified 18 SFs in the KSA. The estimated per capita number of beds/year/100,000 people was 0.11 and the per capita polysomnography (PSG) rate was 18.0 PSG/year/100,000 people. The most important obstacles to the progress of sleep medicine in the KSA were a lack of trained sleep technologists and a lack of sleep medicine specialists. CONCLUSION: The sleep medicine services provided in the KSA have improved since the 2005 survey; however, these services are still below the level of service provided in developed countries. Organized efforts are needed to overcome the identified obstacles and challenges to the progress of sleep medicine in the KSA.
    Annals of Thoracic Medicine 08/2013; 9(1). DOI:10.4103/1817-1737.124444 · 1.80 Impact Factor
  • Source
    • "Effective treatment of OSA with continuous positive airway pressure therapy restores quality of life, improves cognition and at least partially reduces cardiovascular risk (Doherty et al., 2005; Patel et al., 2003). However, OSA remains significantly under-diagnosed, with access to diagnostic facilities one of the key factors limiting more widespread diagnosis (McNicholas, 2008; Tachibana et al., 2005). The reference standard for diagnosis of OSA remains attended overnight polysomnography (PSG) performed in a sleep laboratory (American Academy of Sleep Medicine Task Force., 1999). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Obstructive sleep apnoea is a highly prevalent but under-diagnosed disorder. The gold standard for diagnosis of obstructive sleep apnoea is inpatient polysomnography. This is resource intensive and inconvenient for the patient, and the development of ambulatory diagnostic modalities has been identified as a key research priority. SleepMinder (BiancaMed, NovaUCD, Ireland) is a novel, non-contact, bedside sensor, which uses radio-waves to measure respiration and movement. Previous studies have shown it to be effective in measuring sleep and respiration. We sought to assess its utility in the diagnosis of obstructive sleep apnoea. SleepMinder and polysomnographic assessment of sleep-disordered breathing were performed simultaneously on consecutive subjects recruited prospectively from our sleep clinic. We assessed the diagnostic accuracy of SleepMinder in identifying obstructive sleep apnoea, and how SleepMinder assessment of the apnoea-hypopnoea index correlated with polysomnography. Seventy-four subjects were recruited. The apnoea-hypopnoea index as measured by SleepMinder correlated strongly with polysomnographic measurement (r = 0.90; P ≤ 0.0001). When a diagnostic threshold of moderate-severe (apnoea-hypopnoea index ≥15 events h(-1) ) obstructive sleep apnoea was used, SleepMinder displayed a sensitivity of 90%, a specificity of 92% and an accuracy of 91% in the diagnosis of sleep-disordered breathing. The area under the curve for the receiver operator characteristic was 0.97. SleepMinder correctly classified obstructive sleep apnoea severity in the majority of cases, with only one case different from equivalent polysomnography by more than one diagnostic class. We conclude that in an unselected clinical population undergoing investigation for suspected obstructive sleep apnoea, SleepMinder measurement of sleep-disordered breathing correlates significantly with polysomnography.
    Journal of Sleep Research 11/2012; 22(2). DOI:10.1111/j.1365-2869.2012.01056.x · 3.35 Impact Factor
  • Source
    • "Sleep medicine has witnessed an unprecedented growth in the last two decades due to the growing awareness of obstructive sleep apnea (OSA) and its profound impact on patients' quality of life and health (Tachibana et al., 2005). OSA is a prevalent syndrome characterized by recurrent pauses in respiration, which result in cyclic decreases in blood oxygen saturation and sleep fragmentation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Obstructive sleep apnea (OSA), a highly prevalent breathing disorder in sleep, characterized by intermittent and recurrent pauses in respiration, has emerged as an independent risk factor for cardiovascular morbidity and mortality. Accumulated evidence implicates Leukocyte-endothelial cell activation and adhesion as critical components that induce inflammation and injury to the vasculature resulting in the development of cardiovascular complications. Similar cellular interactions were described in conditions of ischemia/reperfusion, and various components of the metabolic syndrome as hypercholesterolemia and hypertension. The hallmark of sleep apnea--the multiple cycles of hypoxia/reoxygenation--promote oxidative stress and inflammation. These facilitate increased interactions of blood cells with endothelial cells, resulting in endothelial cell injury and dysfunction. Such events can promote atherosclerosis and the development of cardiovascular morbidities in OSA. However, inter-individual differences in response to intermittent hypoxia and activation of anti-inflammatory cytokine profiles in T lymphocytes can serve as protective mechanisms.
    Archives of Physiology and Biochemistry 11/2008; 114(4):244-54. DOI:10.1080/13813450802306701 · 1.76 Impact Factor
Show more